Norwich, United Kingdom
November 28, 2013
We take part in the European Union’s DEANN Project to strengthen scientific partnerships between Latin America and Europe by working together on the challenges of future genomics research.
The Genome Analysis Centre (TGAC) is one of the 12 esteemed entities which make up the DEANN Project’s network, including 6 research institutions and universities in Europe, and 6 research centres in Latin America.
The €928k project, financed by the European Union under the Marie Curie action, will develop an exchange program to fortify collaborations between researchers in the field of genome analysis over four years.
The European-Latin American research network aims to build on the scientific excellence and competitiveness of its members, and to provide a quality framework for the international training of PhD students and post-doctoral researchers.
The DEANN project will tackle challenges in genome sequencing analysis, both in its application to personalised medicine and in biotechnology applications, food processing and environmental.
The project will complete 442 scientific community exchanges and facilitate workshops and summer schools in the field of analysing (Next Generation Sequencing Technologies (NGS) sequencing data, representing the most advanced technologies in genome analysis.
Vicky Schneider, Head of Training & Outreach at The Genome Analysis Centre (TGAC) and Training Coordinator for the DEANN Project, said: “As Training Coordinator for DEANN, I am very proud of TGAC’s integral role in such a prestigious and collaborative international project. We look forward to working closely with the European-Latin American network to provide a shared scientific knowhow community in the field of DNA analysis.”
About TGAC
The Genome Analysis Centre (TGAC) is a research institute focused on the development of genomics and computational biology. TGAC is based within the Norwich Research Park and receives strategic funding from the Biotechnology and Biological Science Research Council (BBSRC) - £9.2M in 2012-2013 - as well as support from other research funders. TGAC is one of eight institutes that receive strategic funding from BBSRC.
TGAC offers state of the art DNA sequencing facility, unique by its operation of multiple complementary technologies for data generation. The Institute is a UK hub for innovative Bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. It is also actively involved in developing novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users and promoting applications of computational Bioscience. Additionally, the Institute offers a Training programme through courses and workshops, and an Outreach programme targeting schools, teachers and the general public through dialogue and science communication activities, www.tgac.ac.uk.
About BBSRC
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, and with an annual budget of around £467M (2012-2013), we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
For more information about BBSRC, our science and our impact see: www.bbsrc.ac.uk.
For more information about BBSRC strategically funded institutes see: www.bbsrc.ac.uk/institutes.
About Centro de Investigación Príncipe Felipe
Acerca de nosotros: El laboratorio de Genómica de la Expresión Génica trabaja en el estudio de los aspectos funcionales de la expresión génica a nivel de todo el genoma y su relación con las enfermedades y rasgos. Para ello desarrollamos métodos estadísticos y herramientas de software que analizan la dinámica del transcriptoma, integrando éstos con otros tipos de datos moleculares y anotándolos funcionalmente, todo ello más recientemente haciendo uso de las tecnologías de secuenciación masiva (NGS). Las áreas actuales de investigación son:
- Patho-transcriptómica: Arquitectura del genoma y regulación de la expresión génica en bacterias patógenas (Chlamydia y Pseudomonas) y hongos (Aspergillus y Fusarium).
- Genómica y epigenómica en Lupus Eritomatoso Sistémico.
- Marcadores epigenómicos en neuroblastoma para el diagnóstico y el pronóstico.
- Biología de Sistemas en el sistema inmune y su asociación con la leucemia.
- El papel funcional de ARN largo no codificante y su asociación con la enfermedad.
La investigación genómica funcional se complementa con el desarrollo de software de bioinformática para el análisis de datos: Blast2GO (anotación funcional), Paintomics (visualización genómica), Qualimap (Control de Calidad de datos NGS), maSigPro y SEA (análisis de series temporales), minAS y ASCA-genes (análisis de la expresión génica) y NOIseq (análisis RNA-seq).
El laboratorio es actualmente coordinador de dos proyectos de investigación del 7PM: STATegra, para el desarrollo de herramientas estadísticas para la integración de datos ómicoss heterogéneos y DEANN, una Marie Curie IRSES para el desarrollo de una red de análisis de NGS entre Europa y Sudamérica.
Species
